244
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment

ORCID Icon, , ORCID Icon, , , , & show all
Pages 2405-2417 | Published online: 25 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Samer Hasan Hussein-Al-Ali, Mohd Zobir Hussein, Saifullah Bullo & Palanisamy Arulselvan. (2021) Chlorambucil-Iron Oxide Nanoparticles as a Drug Delivery System for Leukemia Cancer Cells. International Journal of Nanomedicine 16, pages 6205-6216.
Read now

Articles from other publishers (4)

Yulin Fan & Zhijun Yang. (2022) Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application. Pharmaceutics 14:6, pages 1193.
Crossref
Shamama Javed, Bharti Mangla, Yosif Almoshari, Muhammad H. Sultan & Waquar Ahsan. (2022) Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnology Reviews 11:1, pages 1744-1777.
Crossref
Nasser Alhajj, Niall J. O'Reilly & Helen Cathcart. (2022) Developing ciprofloxacin dry powder for inhalation: A story of challenges and rational design in the treatment of cystic fibrosis lung infection. International Journal of Pharmaceutics 613, pages 121388.
Crossref
Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Lenah S. Binmahfouz, Rana Bakur Bakhaidar, Nagaraja Sreeharsha, Anroop B. Nair & Chandramouli Ramnarayanan. (2021) Aerosol Delivery of Surfactant Liposomes for Management of Pulmonary Fibrosis: An Approach Supporting Pulmonary Mechanics. Pharmaceutics 13:11, pages 1851.
Crossref